Summary:
Medication-assisted treatment, the current standard for opioid addiction, is the use of medications in combination with counseling and behavioral therapies to provide a “whole-patient” approach to the treatment of opioid use disorder (OUD). However, patients may not have optimal access to faceto-face clinical behavioral health services. Digital therapeutics can help bridge the gap between accessible services and optimal treatment of OUD, the primary goal of which is to reduce the use of opioids. OXD01 is a device-based digital therapeutic, designed to offer individuals diagnosed with OUD quality psychotherapy intervention based on cognitive behavioral therapy and motivational interviewing. This study is being conducted to determine the value of OXD01 when combined with medication to change opioid use patterns in subjects with OUD
Criteria:• Male or female 18 - 65 years of age
• Voluntarily seeking treament for OUD
• Have a positive urine drug screen for opioids at first visit
• Must comply with study procedures
• Have no ongoinglegal matters pertaining to their drug history
* Not currently in treatment with Sub -oxone
Qualified Participants May Receive:
Compensation for time and travel upon qualifications and completed study visits.